Quote:
Originally Posted by Ramrod
I was quite detailed about the failings of this system. The CDC followed about 10 million jabbed people so, no, we don't have the biggest cohort. (and they found significant side effects, as did the MHRA) Did you actually read what I wrote?
|
Apologies, I wasn’t clear in what I wrote. In terms of cohort size, the standard passive post market surveillance cohort (Yellow Card for example) is the entire vaccinated population of not just the UK but the world. Regulatory bodies can and do share data.
On top of that, the Rapid Cycle Analysis discussed in that previous link actively data mines 13 million patient records in the UK.
There are of course rare incidences of serious side effects but there will always be a risk/benefit calculation performed
=================================
Edit - Found the global database of adverse drug reactions. Vigibase run from Uppsala in Sweden is the WHO run database